Evaluation of the ALS Clinical Trial Landscape

This technical report evaluates the landscape of clinical trials for Amyotrophic Lateral Sclerosis (ALS), focusing on discoverability and navigation challenges faced by patients. It outlines the critical need for research and development of disease-modifying therapies, as current treatment options are limited and often ineffective. The report discusses factors that restrict access to clinical trials, including stringent entry criteria, geographical barriers, and the burden of participation on patients and caregivers. It emphasizes the importance of understanding these barriers to improve trial enrollment and retention. The document also highlights the role of clinical trial navigators and the necessity for clear communication and support for patients and their families throughout the trial process. Additionally, it presents strategies for enhancing trial visibility and awareness within the ALS community, advocating for the use of online platforms and community engagement to reach potential participants effectively.